AI Engines For more Details: Perplexity Kagi Labs You
Normalization of Heart Rhythm: Propafenone hydrochloride helps to restore and maintain a normal heart rhythm by blocking certain electrical signals in the heart that can cause irregular heartbeats.
Control of Atrial Fibrillation and Flutter: This medication is particularly effective in treating atrial fibrillation and atrial flutter, which are common types of irregular heart rhythms characterized by rapid and irregular heartbeats originating in the upper chambers of the heart (atria).
Reduction of Symptoms: By restoring a regular heart rhythm, propafenone hydrochloride can alleviate symptoms associated with atrial fibrillation and flutter, such as palpitations, chest discomfort, shortness of breath, and fatigue.
Antiarrhythmic Effect: Propafenone hydrochloride exerts its therapeutic effect by blocking sodium channels in cardiac cells, which slows down the conduction of electrical impulses and stabilizes the heart's rhythm.
Blood Pressure Regulation: Propafenone hydrochloride may have mild blood pressure-lowering effects, which can be beneficial for individuals with high blood pressure or hypertension.
Side Effects: Common side effects of propafenone hydrochloride may include dizziness, lightheadedness, nausea, vomiting, constipation, and blurred vision. These side effects are usually mild and transient but may require medical attention if they persist or worsen.
Proarrhythmic Effects: Like other antiarrhythmic medications, propafenone hydrochloride has the potential to cause proarrhythmia, which is the worsening or emergence of new arrhythmias. Patients taking this medication should be closely monitored for any signs of arrhythmia recurrence or exacerbation.
Interactions: Propafenone hydrochloride may interact with other medications, including other antiarrhythmics, anticoagulants, beta-blockers, and certain antibiotics. It's essential for patients to inform their healthcare provider about all medications they are taking to avoid potential drug interactions.
Liver Function Monitoring: Propafenone hydrochloride is metabolized in the liver, so individuals with liver impairment may require dose adjustments or closer monitoring to avoid potential adverse effects.
Caution in Certain Populations: Propafenone hydrochloride should be used with caution in patients with pre-existing heart conditions, liver or kidney dysfunction, and those who are pregnant or breastfeeding.
Rank | Probiotic | Impact |
---|---|---|
species | Akkermansia muciniphila | Reduces |
species | Anaerobutyricum hallii | Reduces |
species | Bacteroides uniformis | Reduces |
species | Blautia wexlerae | Reduces |
species | Christensenella minuta | Reduces |
species | Enterococcus faecium | Reduces |
species | Escherichia coli | Reduces |
species | Lactococcus cremoris | Reduces |
species | Parabacteroides distasonis | Reduces |
We extend modifiers to include items that changes the parent and child taxa. I.e. for a species, that would be the genus that is belongs to and the strains in the species.
π Direct Citations | πͺπΆ Indirect Citations | Taxonomy | Rank | Effect |
---|---|---|---|---|
0 | 1 | Akkermansiaceae | family | Decreases |
0 | 2 | Escherichia | genus | Decreases |
0 | 1 | Agathobacter | genus | Decreases |
0 | 1 | Segatella | genus | Decreases |
0 | 1 | Coprococcus | genus | Decreases |
1 | 0 | Akkermansia | genus | Decreases |
0 | 1 | Candida | genus | Decreases |
0 | 1 | Staphylococcus | genus | Decreases |
0 | 1 | Enterocloster | genus | Decreases |
0 | 1 | Lachnospira | genus | Decreases |
0 | 1 | Ruminococcus | genus | Decreases |
0 | 1 | Eggerthella | genus | Decreases |
0 | 1 | Bacteroides | genus | Decreases |
0 | 1 | Shigella | genus | Decreases |
0 | 1 | Bilophila | genus | Decreases |
0 | 1 | Mediterraneibacter | genus | Decreases |
0 | 1 | Leyella | genus | Decreases |
0 | 1 | Fusobacterium | genus | Decreases |
0 | 1 | Parabacteroides | genus | Decreases |
0 | 2 | Escherichia coli O1:K1:H7 | no rank | Decreases |
0 | 2 | Escherichia coli O139:H1 | no rank | Decreases |
0 | 2 | Escherichia coli O141:H4 | no rank | Decreases |
0 | 2 | Escherichia coli O145:H34 | no rank | Decreases |
0 | 2 | Escherichia coli O15:H12 | no rank | Decreases |
0 | 2 | Escherichia coli O155:H21 | no rank | Decreases |
0 | 2 | Escherichia coli O158:H23 | no rank | Decreases |
0 | 2 | Escherichia coli O16:H48 | no rank | Decreases |
0 | 2 | Escherichia coli O170:H18 | no rank | Decreases |
0 | 2 | Escherichia coli O18ac:H14 | no rank | Decreases |
0 | 2 | Escherichia coli O19:H7 | no rank | Decreases |
0 | 2 | Escherichia coli O2:K1:H4 | no rank | Decreases |
0 | 2 | Escherichia coli O2:K1:H5 | no rank | Decreases |
0 | 2 | Escherichia coli O2:K1:H7 | no rank | Decreases |
0 | 2 | Escherichia coli O20:H12 | no rank | Decreases |
0 | 2 | Escherichia coli O25:H16 | no rank | Decreases |
0 | 2 | Escherichia coli O55:H7 | no rank | Decreases |
0 | 2 | Escherichia coli O68:H12 | no rank | Decreases |
0 | 2 | Escherichia coli O7:H15 | no rank | Decreases |
0 | 2 | Escherichia coli O78:H51 | no rank | Decreases |
0 | 2 | Escherichia coli O80:H26 | no rank | Decreases |
0 | 2 | Escherichia coli O84:H7 | no rank | Decreases |
0 | 2 | Escherichia coli O85:H1 | no rank | Decreases |
0 | 1 | environmental samples | no rank | Decreases |
0 | 1 | unclassified Akkermansia | no rank | Decreases |
0 | 2 | Escherichia coli O103 | serogroup | Decreases |
0 | 2 | Escherichia coli O111 | serogroup | Decreases |
0 | 2 | Escherichia coli O119 | serogroup | Decreases |
0 | 2 | Escherichia coli O121 | serogroup | Decreases |
0 | 2 | Escherichia coli O145 | serogroup | Decreases |
0 | 2 | Escherichia coli O155 | serogroup | Decreases |
0 | 2 | Escherichia coli O157 | serogroup | Decreases |
0 | 2 | Escherichia coli O177 | serogroup | Decreases |
0 | 2 | Escherichia coli O26 | serogroup | Decreases |
0 | 2 | Escherichia coli O3 | serogroup | Decreases |
0 | 2 | Escherichia coli O43 | serogroup | Decreases |
0 | 2 | Escherichia coli O5 | serogroup | Decreases |
0 | 2 | Escherichia coli O78 | serogroup | Decreases |
0 | 2 | Escherichia coli O86 | serogroup | Decreases |
0 | 2 | Escherichia coli O91 | serogroup | Decreases |
0 | 2 | Escherichia coli H20 | serotype | Decreases |
0 | 2 | Escherichia coli O1:H42 | serotype | Decreases |
0 | 2 | Escherichia coli O1:HNT | serotype | Decreases |
0 | 2 | Escherichia coli O10:H32 | serotype | Decreases |
0 | 2 | Escherichia coli O10:K5(L):H4 | serotype | Decreases |
0 | 2 | Escherichia coli O100:H21 | serotype | Decreases |
0 | 2 | Escherichia coli O103:H11 | serotype | Decreases |
0 | 2 | Escherichia coli O103:H2 | serotype | Decreases |
0 | 2 | Escherichia coli O103:H25 | serotype | Decreases |
0 | 2 | Escherichia coli O104:H21 | serotype | Decreases |
0 | 2 | Escherichia coli O104:H4 | serotype | Decreases |
0 | 2 | Escherichia coli O111:H- | serotype | Decreases |
0 | 2 | Escherichia coli O111:H11 | serotype | Decreases |
0 | 2 | Escherichia coli O111:H8 | serotype | Decreases |
0 | 2 | Escherichia coli O111:NM | serotype | Decreases |
0 | 2 | Escherichia coli O112ab:H8 | serotype | Decreases |
0 | 2 | Escherichia coli O112ac:H19 | serotype | Decreases |
0 | 2 | Escherichia coli O113:H21 | serotype | Decreases |
0 | 2 | Escherichia coli O114:H49 | serotype | Decreases |
0 | 2 | Escherichia coli O118:H16 | serotype | Decreases |
0 | 2 | Escherichia coli O121:H19 | serotype | Decreases |
0 | 2 | Escherichia coli O121:H7 | serotype | Decreases |
0 | 2 | Escherichia coli O123:H11 | serotype | Decreases |
0 | 2 | Escherichia coli O125ac:K+:H10 | serotype | Decreases |
0 | 2 | Escherichia coli O126:H45 | serotype | Decreases |
0 | 2 | Escherichia coli O127:H27 | serotype | Decreases |
0 | 2 | Escherichia coli O127:H6 | serotype | Decreases |
0 | 2 | Escherichia coli O128:H2 | serotype | Decreases |
0 | 2 | Escherichia coli O128ac:H12 | serotype | Decreases |
0 | 2 | Escherichia coli O139:H28 | serotype | Decreases |
0 | 2 | Escherichia coli O145:H25 | serotype | Decreases |
0 | 2 | Escherichia coli O145:H28 | serotype | Decreases |
0 | 2 | Escherichia coli O145:NM | serotype | Decreases |
0 | 2 | Escherichia coli O146:H21 | serotype | Decreases |
0 | 2 | Escherichia coli O15:H18 | serotype | Decreases |
0 | 2 | Escherichia coli O150:H6 | serotype | Decreases |
0 | 2 | Escherichia coli O152:H23 | serotype | Decreases |
0 | 2 | Escherichia coli O153:H2 | serotype | Decreases |
0 | 2 | Escherichia coli O156:H25 | serotype | Decreases |
0 | 2 | Escherichia coli O157:H- | serotype | Decreases |
0 | 2 | Escherichia coli O157:H43 | serotype | Decreases |
0 | 2 | Escherichia coli O157:H7 | serotype | Decreases |
0 | 2 | Escherichia coli O157:NM | serotype | Decreases |
0 | 2 | Escherichia coli O16:H6 | serotype | Decreases |
0 | 2 | Escherichia coli O165:H25 | serotype | Decreases |
0 | 2 | Escherichia coli O167:H26 | serotype | Decreases |
0 | 2 | Escherichia coli O174:H2 | serotype | Decreases |
0 | 2 | Escherichia coli O174:H21 | serotype | Decreases |
0 | 2 | Escherichia coli O174:H8 | serotype | Decreases |
0 | 2 | Escherichia coli O176:H45 | serotype | Decreases |
0 | 2 | Escherichia coli O177:NM | serotype | Decreases |
0 | 2 | Escherichia coli O2:H6 | serotype | Decreases |
0 | 2 | Escherichia coli O2:K2:H1 | serotype | Decreases |
0 | 2 | Escherichia coli O25:H1 | serotype | Decreases |
0 | 2 | Escherichia coli O25:NM | serotype | Decreases |
0 | 2 | Escherichia coli O26:H1 | serotype | Decreases |
0 | 2 | Escherichia coli O26:H11 | serotype | Decreases |
0 | 2 | Escherichia coli O28ac:NM | serotype | Decreases |
0 | 2 | Escherichia coli O29:H4 | serotype | Decreases |
0 | 2 | Escherichia coli O32:H37 | serotype | Decreases |
0 | 2 | Escherichia coli O39:NM | serotype | Decreases |
0 | 2 | Escherichia coli O44:H18 | serotype | Decreases |
0 | 2 | Escherichia coli O45:H2 | serotype | Decreases |
0 | 2 | Escherichia coli O6:H16 | serotype | Decreases |
0 | 2 | Escherichia coli O6:H16:CFA/II | serotype | Decreases |
0 | 2 | Escherichia coli O6:K2:H1 | serotype | Decreases |
0 | 2 | Escherichia coli O69:H11 | serotype | Decreases |
0 | 2 | Escherichia coli O7:H4 | serotype | Decreases |
0 | 2 | Escherichia coli O7:K1 | serotype | Decreases |
0 | 2 | Escherichia coli O78:H12 | serotype | Decreases |
0 | 2 | Escherichia coli O78:H4 | serotype | Decreases |
0 | 2 | Escherichia coli O79:H7 | serotype | Decreases |
0 | 2 | Escherichia coli O8:H8 | serotype | Decreases |
0 | 2 | Escherichia coli O81:NM | serotype | Decreases |
0 | 2 | Escherichia coli O83:H1 | serotype | Decreases |
0 | 2 | Escherichia coli O86:H34 | serotype | Decreases |
0 | 2 | Escherichia coli O89m:H10 | serotype | Decreases |
0 | 2 | Escherichia coli O89m:H9 | serotype | Decreases |
0 | 2 | Escherichia coli O9:H10 | serotype | Decreases |
0 | 2 | Escherichia coli O91:H14 | serotype | Decreases |
0 | 2 | Escherichia coli O91:NM | serotype | Decreases |
0 | 2 | Escherichia coli O99:H6 | serotype | Decreases |
0 | 2 | Escherichia coli ONT:H33 | serotype | Decreases |
2 | 0 | Escherichia coli | species | Decreases |
1 | 0 | Agathobacter rectalis | species | Decreases |
1 | 0 | Segatella copri | species | Decreases |
1 | 0 | Coprococcus comes | species | Decreases |
1 | 0 | Akkermansia muciniphila | species | Decreases |
1 | 0 | Candida albicans | species | Decreases |
1 | 0 | Staphylococcus aureus | species | Decreases |
1 | 0 | Enterocloster bolteae | species | Decreases |
1 | 0 | Lachnospira eligens | species | Decreases |
1 | 0 | Ruminococcus bromii | species | Decreases |
1 | 0 | Bacteroides uniformis | species | Decreases |
1 | 0 | Eggerthella lenta | species | Decreases |
1 | 0 | Bacteroides fragilis | species | Decreases |
0 | 1 | Anaerobutyricum hallii | species | Decreases |
0 | 1 | Blautia sp. SC05B48 | species | Decreases |
0 | 1 | Komagataeibacter oboediens | species | Decreases |
1 | 0 | Bilophila wadsworthia | species | Decreases |
0 | 1 | Shigella dysenteriae | species | Decreases |
0 | 1 | Lachnoanaerobaculum gingivalis | species | Decreases |
0 | 1 | Blautia liquoris | species | Decreases |
0 | 1 | Segatella bryantii | species | Decreases |
0 | 1 | Shigella flexneri | species | Decreases |
0 | 1 | Escherichia albertii | species | Decreases |
1 | 0 | Mediterraneibacter gnavus | species | Decreases |
0 | 1 | Faecalitalea cylindroides | species | Decreases |
0 | 1 | Coprococcus catus | species | Decreases |
0 | 1 | Novisyntrophococcus fermenticellae | species | Decreases |
0 | 1 | Dorea longicatena | species | Decreases |
0 | 1 | Butyrivibrio crossotus | species | Decreases |
0 | 1 | Qiania dongpingensis | species | Decreases |
0 | 1 | Leyella stercorea | species | Decreases |
0 | 1 | Escherichia fergusonii | species | Decreases |
0 | 1 | Dorea formicigenerans | species | Decreases |
0 | 1 | Blautia obeum | species | Decreases |
0 | 1 | Coprococcus eutactus | species | Decreases |
0 | 1 | Eubacterium sp. MSJ-33 | species | Decreases |
0 | 1 | Wansuia hejianensis | species | Decreases |
0 | 1 | Ligilactobacillus ruminis | species | Decreases |
0 | 1 | Clostridium cadaveris | species | Decreases |
0 | 1 | [Ruminococcus] lactaris | species | Decreases |
0 | 1 | Anaerostipes hadrus | species | Decreases |
0 | 1 | Lactococcus cremoris | species | Decreases |
0 | 1 | Eubacterium ventriosum | species | Decreases |
0 | 1 | Lachnoclostridium phocaeense | species | Decreases |
0 | 1 | Bacteroides humanifaecis | species | Decreases |
0 | 1 | Marvinbryantia formatexigens | species | Decreases |
0 | 1 | Streptococcus suis | species | Decreases |
0 | 1 | Shigella boydii | species | Decreases |
0 | 1 | Roseburia hominis | species | Decreases |
0 | 1 | Clostridium sp. M62/1 | species | Decreases |
0 | 1 | Longicatena caecimuris | species | Decreases |
0 | 1 | Lacrimispora saccharolytica | species | Decreases |
0 | 1 | Clostridium sp. SY8519 | species | Decreases |
0 | 1 | Coprococcus sp. ART55/1 | species | Decreases |
0 | 1 | Wujia chipingensis | species | Decreases |
1 | 0 | Fusobacterium nucleatum | species | Decreases |
0 | 1 | Faecalibacterium duncaniae | species | Decreases |
0 | 1 | Solibaculum mannosilyticum | species | Decreases |
0 | 1 | Adlercreutzia equolifaciens | species | Decreases |
0 | 1 | [Ruminococcus] torques | species | Decreases |
0 | 1 | Christensenella minuta | species | Decreases |
0 | 1 | Faecalibacterium sp. I4-1-79 | species | Decreases |
0 | 1 | Catenibacterium sp. co_0103 | species | Decreases |
0 | 1 | Pseudobutyrivibrio xylanivorans | species | Decreases |
0 | 1 | Roseburia rectibacter | species | Decreases |
0 | 1 | Ruminococcus gauvreauii | species | Decreases |
0 | 1 | Enterocloster clostridioformis | species | Decreases |
0 | 1 | Maliibacterium massiliense | species | Decreases |
0 | 1 | Bacteroides sp. A1C1 | species | Decreases |
0 | 1 | Adlercreutzia hattorii | species | Decreases |
0 | 1 | Faecalibacterium sp. HTF-F | species | Decreases |
0 | 1 | Catenibacterium mitsuokai | species | Decreases |
0 | 1 | Faecalibacterium sp. I2-3-92 | species | Decreases |
0 | 1 | Simiaoa sunii | species | Decreases |
0 | 1 | Bacteroides sp. CACC 737 | species | Decreases |
0 | 1 | Fannyhessea vaginae | species | Decreases |
0 | 1 | Blautia wexlerae | species | Decreases |
0 | 1 | Treponema peruense | species | Decreases |
0 | 1 | Bacillus paralicheniformis | species | Decreases |
0 | 1 | Massilistercora timonensis | species | Decreases |
0 | 1 | Faecalibacterium sp. IP-3-29 | species | Decreases |
0 | 1 | Ruminococcus bicirculans (ex Wegman et al. 2014) | species | Decreases |
0 | 1 | Faecalibacterium sp. IP-1-18 | species | Decreases |
0 | 1 | Roseburia intestinalis | species | Decreases |
0 | 1 | Subdoligranulum variabile | species | Decreases |
0 | 1 | Eubacterium sp. c-25 | species | Decreases |
0 | 1 | Parvimonas micra | species | Decreases |
0 | 1 | Faecalibacillus intestinalis | species | Decreases |
0 | 1 | Enterococcus cecorum | species | Decreases |
0 | 1 | Faecalibacterium sp. I3-3-33 | species | Decreases |
0 | 1 | Faecalibacterium sp. I3-3-89 | species | Decreases |
0 | 1 | Prevotella intermedia | species | Decreases |
0 | 1 | [Clostridium] hylemonae | species | Decreases |
0 | 1 | Faecalibaculum rodentium | species | Decreases |
0 | 1 | Flavonifractor plautii | species | Decreases |
0 | 1 | Intestinibaculum porci | species | Decreases |
0 | 1 | Enterococcus faecium | species | Decreases |
0 | 1 | Ruminococcus bovis | species | Decreases |
0 | 1 | Hungatella hathewayi | species | Decreases |
0 | 1 | Mogibacterium diversum | species | Decreases |
0 | 1 | Eggerthella guodeyinii | species | Decreases |
0 | 1 | Ruminococcus champanellensis | species | Decreases |
0 | 1 | Treponema denticola | species | Decreases |
0 | 1 | Faecalibacterium sp. I4-3-84 | species | Decreases |
0 | 1 | Leyella lascolaii | species | Decreases |
0 | 1 | Actinomyces oris | species | Decreases |
0 | 1 | Mageeibacillus indolicus | species | Decreases |
0 | 1 | Shigella sonnei | species | Decreases |
0 | 1 | Chordicoccus furentiruminis | species | Decreases |
0 | 1 | Emergencia timonensis | species | Decreases |
0 | 1 | Eubacterium limosum | species | Decreases |
0 | 1 | Anaerotruncus colihominis | species | Decreases |
0 | 1 | Vescimonas fastidiosa | species | Decreases |
0 | 1 | Monoglobus pectinilyticus | species | Decreases |
0 | 1 | Oscillibacter hominis | species | Decreases |
0 | 1 | Escherichia marmotae | species | Decreases |
0 | 1 | Ruminococcus albus | species | Decreases |
0 | 1 | Turicibacter bilis | species | Decreases |
0 | 1 | Corynebacterium durum | species | Decreases |
0 | 1 | Eubacterium maltosivorans | species | Decreases |
0 | 1 | Paraprevotella clara | species | Decreases |
0 | 1 | [Eubacterium] hominis | species | Decreases |
0 | 1 | Phascolarctobacterium succinatutens | species | Decreases |
0 | 1 | Prevotella bivia | species | Decreases |
0 | 1 | Butyrivibrio fibrisolvens | species | Decreases |
0 | 1 | Escherichia sp. E4742 | species | Decreases |
0 | 1 | Clostridioides difficile | species | Decreases |
0 | 1 | Eubacterium callanderi | species | Decreases |
0 | 1 | Olsenella sp. oral taxon 807 | species | Decreases |
0 | 1 | Acutalibacter muris | species | Decreases |
0 | 1 | Romboutsia ilealis | species | Decreases |
0 | 1 | Butyricicoccus sp. GAM44 | species | Decreases |
0 | 1 | Vescimonas coprocola | species | Decreases |
0 | 1 | Prevotella dentalis | species | Decreases |
0 | 1 | Akkermansia glycaniphila | species | Decreases |
0 | 1 | Akkermansia massiliensis | species | Decreases |
0 | 1 | Candidatus Akkermansia intestinavium | species | Decreases |
1 | 0 | Parabacteroides distasonis | species | Decreases |
0 | 1 | Fusobacterium nucleatum subsp. nucleatum | subspecies | Decreases |
A higher number indicates impact on more bacteria associated with the condition and confidence on the impact.
We have X bacteria high and Y low reported. We find that the modifier reduces some and increases other of these two groups. We just tally: X|reduces + Y|Increase = Positive X|increases + Y|decrease = Negative.
Benefit Ratio:
Numbers above 0 have increasing positive effect.
Numbers below 0 have increasing negative effect.
Condition | Positive Impact | Negative Impact | Benefit Ratio Impact |
---|---|---|---|
Abdominal Aortic Aneurysm | 0.1 | 0.1 | |
Acne | 0.5 | 0.5 | |
ADHD | 1.7 | 0.9 | 0.89 |
Age-Related Macular Degeneration and Glaucoma | 0.2 | 0 | 0 |
Allergic Rhinitis (Hay Fever) | 1.7 | 0.9 | 0.89 |
Allergies | 3.4 | 2.8 | 0.21 |
Allergy to milk products | 1.9 | 0.7 | 1.71 |
Alopecia (Hair Loss) | 0.1 | 0.1 | 0 |
Alzheimer's disease | 3.9 | 3.5 | 0.11 |
Amyotrophic lateral sclerosis (ALS) Motor Neuron | 2.4 | 1.3 | 0.85 |
Ankylosing spondylitis | 2.8 | 0.9 | 2.11 |
Anorexia Nervosa | 0.3 | 1.3 | -3.33 |
Antiphospholipid syndrome (APS) | 0.9 | 0.1 | 8 |
Asthma | 2.9 | 1.4 | 1.07 |
Atherosclerosis | 2.1 | 0.4 | 4.25 |
Atrial fibrillation | 2.2 | 1.9 | 0.16 |
Autism | 5.7 | 5 | 0.14 |
Autoimmune Disease | 0.4 | 0.4 | |
Barrett esophagus cancer | 0.1 | 0.1 | |
benign prostatic hyperplasia | 0.6 | 0.2 | 2 |
Biofilm | 2.1 | 2.1 | |
Bipolar Disorder | 1.1 | 0.7 | 0.57 |
Brain Trauma | 0.7 | 0.6 | 0.17 |
Breast Cancer | 0.6 | 0.6 | |
Cancer (General) | 0.1 | 0.4 | -3 |
Carcinoma | 1.2 | 0.4 | 2 |
Celiac Disease | 1.8 | 1 | 0.8 |
Cerebral Palsy | 0.4 | 0.4 | 0 |
Chronic Fatigue Syndrome | 3.1 | 3.2 | -0.03 |
Chronic Kidney Disease | 1.5 | 2 | -0.33 |
Chronic Lyme | 0.1 | 0.2 | -1 |
Chronic Obstructive Pulmonary Disease (COPD) | 1.8 | 0.6 | 2 |
Chronic Urticaria (Hives) | 0.7 | 1.4 | -1 |
Coagulation / Micro clot triggering bacteria | 1.4 | 0.2 | 6 |
Cognitive Function | 0.4 | 0.4 | |
Colorectal Cancer | 2.9 | 1.3 | 1.23 |
Constipation | 1 | 1 | |
Coronary artery disease | 2.3 | 1.8 | 0.28 |
COVID-19 | 5.3 | 6.7 | -0.26 |
Crohn's Disease | 4.6 | 3.4 | 0.35 |
Cushing's Syndrome (hypercortisolism) | 0.5 | 0.2 | 1.5 |
cystic fibrosis | 1.2 | 0.2 | 5 |
d-lactic acidosis (one form of brain fog) | 1 | 1 | |
deep vein thrombosis | 2.3 | 0.4 | 4.75 |
Denture Wearers Oral Shifts | 1.5 | 1.5 | |
Depression | 5.1 | 4.3 | 0.19 |
Dermatomyositis | 0.5 | 0.5 | |
Eczema | 1.4 | 0.3 | 3.67 |
Endometriosis | 2.2 | 1.2 | 0.83 |
Eosinophilic Esophagitis | 0.1 | 0.1 | |
Epilepsy | 1.8 | 1 | 0.8 |
erectile dysfunction | 0.6 | 0.6 | |
Fibromyalgia | 1 | 1.7 | -0.7 |
Functional constipation / chronic idiopathic constipation | 2.7 | 1.9 | 0.42 |
gallstone disease (gsd) | 1.6 | 0.3 | 4.33 |
Gastroesophageal reflux disease (Gerd) including Barrett's esophagus | 0.5 | 1 | -1 |
Generalized anxiety disorder | 2 | 0.7 | 1.86 |
Gout | 1.1 | 0.7 | 0.57 |
Graves' disease | 0.4 | 0.5 | -0.25 |
Gulf War Syndrome | 0.3 | 1.1 | -2.67 |
Halitosis | 0.4 | 0.4 | |
Hashimoto's thyroiditis | 1.4 | 0.9 | 0.56 |
Heart Failure | 3 | 1.3 | 1.31 |
hemorrhagic stroke | 0.1 | 0.1 | |
Hidradenitis Suppurativa | 1.4 | 1.4 | |
High Histamine/low DAO | 0.7 | 0.2 | 2.5 |
hypercholesterolemia (High Cholesterol) | 0.5 | 0.6 | -0.2 |
hyperglycemia | 1.2 | 1 | 0.2 |
Hyperlipidemia (High Blood Fats) | 0.4 | 0.4 | |
hypersomnia | 0.1 | -0.1 | |
hypertension (High Blood Pressure | 2.2 | 2.2 | 0 |
Hypothyroidism | 0.9 | 0.4 | 1.25 |
Hypoxia | 0.5 | 0.5 | |
IgA nephropathy (IgAN) | 1.2 | 2.1 | -0.75 |
Inflammatory Bowel Disease | 3.6 | 6 | -0.67 |
Insomnia | 1.5 | 2.3 | -0.53 |
Intelligence | 1.3 | 0.6 | 1.17 |
Intracranial aneurysms | 0.6 | 0.4 | 0.5 |
Irritable Bowel Syndrome | 3.3 | 2.2 | 0.5 |
ischemic stroke | 0.9 | 1 | -0.11 |
Juvenile idiopathic arthritis | 0.5 | 0.5 | |
Liver Cirrhosis | 3.7 | 2.5 | 0.48 |
Long COVID | 3.6 | 3.4 | 0.06 |
Low bone mineral density | 0.8 | -0.8 | |
Lung Cancer | 0.5 | 1 | -1 |
Lymphoma | 0.4 | 0.4 | |
Mast Cell Issues / mastitis | 1.3 | 0.5 | 1.6 |
ME/CFS with IBS | 0.5 | 1.8 | -2.6 |
ME/CFS without IBS | 0.9 | 0.7 | 0.29 |
Menopause | 0.2 | 0.4 | -1 |
Metabolic Syndrome | 3.4 | 3.2 | 0.06 |
Mood Disorders | 4.9 | 3.9 | 0.26 |
multiple chemical sensitivity [MCS] | 0.3 | 0.3 | |
Multiple Sclerosis | 3.3 | 3.3 | 0 |
Multiple system atrophy (MSA) | 0.9 | 0.2 | 3.5 |
myasthenia gravis | 0.4 | 0.4 | |
neuropathic pain | 0.2 | 0.9 | -3.5 |
Neuropathy (all types) | 0.4 | 0.3 | 0.33 |
neuropsychiatric disorders (PANDAS, PANS) | 0.5 | 0.5 | |
Nonalcoholic Fatty Liver Disease (nafld) Nonalcoholic | 2.5 | 2.7 | -0.08 |
NonCeliac Gluten Sensitivity | 0.8 | 0.2 | 3 |
Obesity | 5.1 | 3.8 | 0.34 |
obsessive-compulsive disorder | 3.2 | 2.4 | 0.33 |
Osteoarthritis | 2 | 0.8 | 1.5 |
Osteoporosis | 1.4 | 0.7 | 1 |
pancreatic cancer | 0.4 | 0.4 | |
Parkinson's Disease | 4.8 | 4.1 | 0.17 |
Polycystic ovary syndrome | 2.4 | 1.2 | 1 |
Postural orthostatic tachycardia syndrome | 0.3 | -0.3 | |
Premenstrual dysphoric disorder | 0.3 | 0 | 0 |
primary biliary cholangitis | 0.5 | -0.5 | |
Primary sclerosing cholangitis | 0.4 | 1.4 | -2.5 |
Psoriasis | 2.2 | 2.3 | -0.05 |
rheumatoid arthritis (RA),Spondyloarthritis (SpA) | 4.6 | 1.4 | 2.29 |
Rosacea | 0.8 | 0.8 | |
Schizophrenia | 3.4 | 1.2 | 1.83 |
scoliosis | 1.4 | 0.8 | 0.75 |
sensorineural hearing loss | 1 | 1 | |
Sjögren syndrome | 1 | 1 | 0 |
Sleep Apnea | 0.7 | 0.6 | 0.17 |
Slow gastric motility / Gastroparesis | 0.9 | 0.9 | |
Small Intestinal Bacterial Overgrowth (SIBO) | 1.4 | 1.4 | |
Stress / posttraumatic stress disorder | 1.4 | 1.3 | 0.08 |
Systemic Lupus Erythematosus | 2.8 | 0.6 | 3.67 |
Tic Disorder | 0.2 | 1.1 | -4.5 |
Tourette syndrome | 0.3 | 0.2 | 0.5 |
Type 1 Diabetes | 3.1 | 1.2 | 1.58 |
Type 2 Diabetes | 4.3 | 2.9 | 0.48 |
Ulcerative colitis | 2.3 | 3.5 | -0.52 |
Unhealthy Ageing | 2.4 | 1.2 | 1 |
Vitiligo | 0.9 | 0.9 | 0 |
Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.
Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served. Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β―1030, CETS No.185, CFAA Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license. Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models. Inventions /Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions,
or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]